DNA Stock Ownership Activity

GINKGO BIOWORKS HOLDINGS INC 13F holders

No value investing guru has made any change to the GINKGO BIOWORKS HOLDINGS INC (DNA) position according to the gurus' latest SEC quarterly report(s).

Which gurus or hedge funds are buying DNA now?

According to the latest SEC filing(s) GINKGO BIOWORKS HOLDINGS INC (DNA) has not been purchased by any super investor.

To see more about who is investing in GINKGO BIOWORKS HOLDINGS INC (DNA), please go to the DNA ownership page.

2023 Q1 (1 result)
Ole Andreas Halvorsen
+126.81%
+57,200,000
+0.50%
0.64%
Current price: $0.96 27.82% Reported price*: $1.33
2022 Q4 (1 result)
Ole Andreas Halvorsen
-38.05%
-23,249,400
-0.33%
0.32%
Current price: $0.96 43.20% Reported price*: $1.69
2022 Q3 (1 result)
Ole Andreas Halvorsen
+275.99%
+52,698,750
+1.08%
1.04%
Current price: $0.96 69.23% Reported price*: $3.12
2022 Q2 (1 result)
Ole Andreas Halvorsen
-46.95%
-23,971,018
-0.26%
0.30%
Current price: $0.96 59.66% Reported price*: $2.38
2022 Q1 (2 results)
Ole Andreas Halvorsen
-84.94%
-288,000,000
-4.71%
0.84%
Chase Coleman III
-100.00%
-2,425,000
-0.08%
0.00%
Current price: $0.96 76.18% AVG reported price*: $4.03
2021 Q3 (2 results)
Ole Andreas Halvorsen
buy
+339,055,144
+10.81%
10.81%
Chase Coleman III
buy
+1,600,499
+0.05%
0.04%
Current price: $0.96 91.72% AVG reported price*: $11.59
8 of 8

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.